Aripiprazole
Apra contains the active substance aripiprazole and belongs to a group of medicines called antipsychotics.
It is used to treat adults and adolescents aged 15 years and older with a disease characterized by symptoms such as: seeing, hearing, and feeling things that are not real, suspiciousness, delusions, disorganized thinking and behavior, and emotional flattening. Patients with these symptoms may also feel depressed, anxious, or tense, and may have feelings of guilt.
Apra is used to treat adults and adolescents aged 13 years and older with a disease characterized by symptoms such as: excitement, excessive energy, reduced need for sleep, very fast speech, racing thoughts, and sometimes severe irritability. In adults, this medicine also prevents the recurrence of these symptoms in patients who have responded to treatment with Apra.
Before taking Apra, discuss this with your doctor.
During treatment with aripiprazole, thoughts and behaviors of suicide have been reported. You should immediately inform your doctor if you experience thoughts or feelings of self-harm.
Before taking Apra, tell your doctor if you have:
If you experience weight gain, unusual movements, drowsiness that interferes with your daily activities, difficulty swallowing, or signs of allergy, you should inform your doctor.
If you are an elderly patient with dementia, you or your caregiver should inform your doctor if you have ever had a stroke or "mini" stroke.
You should immediately inform your doctor if you experience thoughts or feelings of self-harm. During treatment with aripiprazole, thoughts and behaviors of suicide have been reported.
You should immediately inform your doctor if you experience muscle stiffness or stiffness with high fever, sweating, changes in mental status, or very fast or irregular heartbeat.
If you or your family/caregiver notice that you are starting to feel the urge or impulse to behave in a way that is unusual for you and you cannot resist the impulse, urge, or temptation to perform an activity that could harm you or others, you should tell your doctor. These behaviors are called impulse control disorders and can be characterized by behaviors such as compulsive gambling, excessive eating or spending, excessive sexual desire, or an increased frequency and intensity of thoughts or feelings about sexual matters.
Your doctor may consider changing your dose or stopping your treatment.
Aripiprazole may cause drowsiness, decreased blood pressure when standing up, dizziness, and changes in your ability to move and balance, which can lead to falls. You should be careful, especially if you are an elderly or weakened patient.
Do not take Apra if you are under 13 years old. It is not known if the medicine is safe and effective in these patients.
Tell your doctor or pharmacist about all the medicines you are taking now or have taken recently, and about any medicines you plan to take, including those that are available without a prescription.
Blood pressure-lowering medicines: Apra may increase the effect of blood pressure-lowering medicines. If you are taking blood pressure-lowering medicines, you should inform your doctor.
Taking Apra with some medicines may require a change in the dose of Apra. It is especially important to inform your doctor about the use of the following medicines:
Taking these medicines may increase the risk of side effects or reduce the effect of Apra. If you experience any unusual symptoms while taking these medicines with Apra, you should inform your doctor.
Medicines that increase serotonin levels are usually used to treat depression, generalized anxiety disorder, obsessive-compulsive disorder (OCD), and social phobia, as well as migraine and pain:
Taking these medicines may increase the risk of side effects. If you experience any unusual symptoms while taking these medicines with Apra, you should inform your doctor.
Apra can be taken with or without food.
During treatment with Apra, you should not drink alcohol.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine.
In newborns whose mothers took aripiprazole during the last trimester (last 3 months of pregnancy), the following symptoms may occur: trembling, muscle stiffness, and (or) weakness, drowsiness, agitation, difficulty breathing, and difficulty feeding. If you notice any of these symptoms in your baby, you should contact your doctor.
If you are taking Apra, your doctor will discuss with you whether you should breastfeed, considering the benefits of the treatment and the benefits of breastfeeding. You should not take the medicine and breastfeed at the same time. You should discuss with your doctor the best way to feed your baby if you are taking this medicine.
During treatment with this medicine, dizziness and vision disturbances may occur (see section 4).
You should take this into account when performing tasks that require full attention, such as driving a vehicle or operating machinery.
Apra 5 mg contains 0.5 mg of aspartame in each tablet.
Apra 10 mg contains 1 mg of aspartame in each tablet.
Apra 15 mg contains 1.5 mg of aspartame in each tablet.
Apra 30 mg contains 3 mg of aspartame in each tablet.
Aspartame is a source of phenylalanine. It may be harmful to patients with phenylketonuria.This is a rare genetic disorder in which phenylalanine accumulates in the body due to its improper elimination.
If you have been diagnosed with an intolerance to some sugars, you should contact your doctor before taking the medicine.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means that the medicine is considered "sodium-free".
Apra 5 mg contains 0.0018 mg of benzyl alcohol in each tablet.
Apra 10 mg contains 0.0036 mg of benzyl alcohol in each tablet.
Apra 15 mg contains 0.0054 mg of benzyl alcohol in each tablet.
Apra 30 mg contains 0.0108 mg of benzyl alcohol in each tablet.
Benzyl alcohol may cause allergic reactions.
Pregnant or breastfeeding women should contact their doctor before taking the medicine, as a large amount of benzyl alcohol may accumulate in their body and cause side effects (such as metabolic acidosis).
Patients with liver or kidney disease should contact their doctor before taking the medicine, as a large amount of benzyl alcohol may accumulate in their body and cause side effects (such as metabolic acidosis).
Always take this medicine exactly as your doctor or pharmacist has told you.
If you are not sure, ask your doctor or pharmacist.
The recommended dose of Apra for adults is 15 mg once a day.However, your doctor may prescribe a lower or higher dose, not exceeding 30 mg once a day.
Treatment with Apra can be started with a low dose of aripiprazole in the form of an oral solution (liquid). The dose can be gradually increased to a recommended dose for adolescents of 10 mg once a day. However, your doctor may prescribe a lower or higher dose, up to a maximum of 30 mg once a day.
If you feel that the effect of the medicine is too strong or too weak, you should consult your doctor or pharmacist.
Apra tablets should be taken once a day at the same time.It does not matter whether the tablet is taken with food or without food. The tablet should be swallowed whole and washed down with water.
Even if you feel better, do not change the dose or stop taking Apra without first consulting your doctor.
If you have taken more Apra tablets than your doctor prescribed (or if someone else has taken some of your Apra tablets), you should immediately contact your doctor. If you cannot contact your doctor, go to the nearest hospital, taking the medicine packaging with you.
In patients who have taken too much aripiprazole, the following symptoms have occurred:
If you miss a dose, you should take the missed dose as soon as you remember. Do not take two doses in one day.
Do not stop treatment just because you feel better.
It is very important to take Apra as prescribed by your doctor and for the duration prescribed by your doctor.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
The following side effects have been reported after the marketing of aripiprazole, but their frequency is not known (the frequency cannot be estimated from the available data):
If you experience such behaviors, you should tell your doctor, who will discuss with you ways to treat or reduce these symptoms.
In elderly patients with dementia taking aripiprazole, more deaths have been reported. Additionally, cases of stroke or "mini" stroke have been recorded.
In adolescents aged 13 years and older, side effects occurred with a similar frequency and type as in adults, except for drowsiness, uncontrolled trembling or movements, restlessness, and fatigue, which occurred very frequently (more than 1 in 10 patients) and abdominal pain, dry mouth, increased heart rate, weight gain, increased appetite, muscle tremors, uncontrolled limb movements, and dizziness, especially when standing up from a lying or sitting position, which occurred frequently (more than 1 in 100 patients).
If you experience any side effects, including those not listed in this leaflet, please inform your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, phone: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the blister and carton.
There are no special storage requirements for the medicinal product.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance of Apra is aripiprazole. Each tablet contains 5 mg, 10 mg, 15 mg, or 30 mg of aripiprazole.
The medicine also contains lactose monohydrate, microcrystalline cellulose, sodium croscarmellose, silicon dioxide, aspartame (E 951), magnesium stearate, vanilla flavor (maltodextrin, gum arabic E 414, propylene glycol E 1520, benzyl alcohol E 1519)
Apra 5 mg tablets: rectangular, biconvex, blue tablets, 7.6 mm x 4.3 mm in size, smooth on both sides.
Apra 10 mg tablets: rectangular, biconvex, pink tablets, 9.3 mm x 5.2 mm in size, smooth on both sides.
Apra 15 mg tablets: round, flat, yellow tablets, 9.0 mm in diameter, smooth on both sides.
Apra 30 mg tablets: round, flat, pink tablets, 10.00 mm in diameter, smooth on both sides.
Apra 5 mg tablets are available in aluminum blisters, packaged in cardboard boxes containing 7, 14, and 28 tablets.
Apra 10 mg, Apra 15 mg, and Apra 30 mg tablets are available in aluminum blisters, packaged in cardboard boxes containing 7, 14, 28, 56, and 84 tablets.
Adamed Pharma S.A.
Pieńków, ul. M. Adamkiewicza 6A
05-152 Czosnów
Rontis Hellas S.A., Medical and Pharmaceutical Products
P.O. Box 3012 Larisa Industrial Area, Larisa
41004 Greece
GENEPHARM S.A.
18th km Marathonos Avenue, Pallini Attiki
15351 Greece
Adamed Pharma S.A.
Pieńków, ul. M. Adamkiewicza 6A
05-152 Czosnów
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.